Gilead Sciences News
12.07 / 17:53
Provident
hiv
country
testing
recommendations
infection
HIV breakthrough: Drug trial shows injection twice a year is 100% effective against infection
HIV infection. The trial tested whether the six-month injection of lenacapavir would provide better protection against HIV infection than two other drugs, both daily pills. All three medications are pre-exposure prophylaxis (or PrEP) drugs. Physician-scientist Linda-Gail Bekker, principal investigator for the South African part of the study, tells Nadine Dreyer what makes this breakthough so significant and what to expect next.
20.06 / 12:13
markets
UPS
Merck
Pfizer
stage
Pharmaceuticals
Why Wall Street is chasing Ozempic wannabes
Gilead Sciences, a biotech company focused on treatments for cancer and HIV, isn’t pitching itself as an obesity drug developer. But that hasn’t stopped some Wall Street analysts from trying to do that on its behalf. Seasoned Jefferies analyst Michael Yee published a market-moving note to investors last week: He dug up recent patents and cross-referenced them with prior data to unearth what looked like the makings of an early-stage metabolic program that could one day become an obesity program.
23.01 / 01:35
Reuters
Food
J&J
information
reports
patient
US FDA requires 'boxed warning' for CAR-T cancer therapies
(Reuters) — The U.S. health regulator said on Monday companies will be required to add a serious warning on the prescribing information for cancer therapies known as CAR-T, made by Gilead Sciences (NASDAQ:GILD), Johnson & Johnson (NYSE:JNJ), Novartis and others.
24.11 / 13:03
Dogecoin
Investing
Entertainment
Netflix
film
Hollywood Meets Crypto: Director Uses Netflix Funds for Risky Dogecoin Bet
Carl Erik Rinsch, the director of “47 Ronin,” allegedly took nearly $60 million that Netflix gave him for a sci-fi series to invest in the crypto and stock markets.
18.11 / 03:15
CEO
Platform
Fighting
Apple
Comcast
Warner Bros
social
reports
elon
Trouble brews for Elon Musk as Disney next brand to pull advertisements off X, after Apple, Lionsgate, Comcast, IBM
Elon Musk's social media platform X, formerly Twitter, in response to the billionaire's public endorsement of antisemitic talk points, as per a CNN report. Musk's controversial statements came at a time when Islamaphobia and antisemitism are on the rise in the US amid the Israel-Gaza war. This is the newest blow for Musk after Apple, Comcast, IBM, Lionsgate, NBCUniversal, Paramount, and Warner Bros.
03.08 / 20:19
details regarding Gilead Sciences
Who is Gilead Sciences?
Gilead Sciences is a notable individual featured in various analyses related to recent developments.
Why is Gilead Sciences attracting attention?
Gilead Sciences frequently draws public interest due to public appearances, which raises concern among experts and the public.
Where can I find the latest news about Gilead Sciences?
Our website has a dedicated section featuring all recent updates related to Gilead Sciences. We continuously monitor developments and update the information promptly.
